-
Agnello V, Abel G, Elfahal M, et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci USA, 1999, 96: 12766-12771.
doi: 10.1073/pnas.96.22.12766
-
Akazawa D, Date T, Morikawa K, et al. CD81 expression is important for the permissiveness of Huh7 cell clones for heterogeneous hepatitis C virus infection. J Virol, 2007, 81: 5036-5045.
doi: 10.1128/JVI.01573-06
-
Andre P, Komurian-Pradel F, Deforges S, et al. Characterization of low-and very-low-density hepatitis C virus RNA-containing particles. J Virol, 2002, 76: 6919-6928.
doi: 10.1128/JVI.76.14.6919-6928.2002
-
Barth H, Cerino R, Arcuri M, et al. Scavenger receptor class B type Ⅰ and hepatitis C virus infection of primary tupaia hepatocytes. J Virol, 2005, 79: 5774-5785.
doi: 10.1128/JVI.79.9.5774-5785.2005
-
Barth H, Liang T J, Baumert T F. Hepatitis C virus entry: molecular biology and clinical implications.Hepatology, 2006, 44: 527-535.
doi: 10.1002/(ISSN)1527-3350
-
Barth H, Schäfer C, Adah M I, et al. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate.J. Biol. Chem., 2003, 278: 41003-41012.
doi: 10.1074/jbc.M302267200
-
Barth H, Schnober E K, Zhang F, et al. Viral and cellular determinants of hepatitis C virus envelope-heparan sulfate interaction. J Virol, 2006, 80 (21): 10579-10590.
doi: 10.1128/JVI.00941-06
-
Barth H, Schnober EK, Zhang F, et al. Viral and cellular determinants of the hepatitis C virus envelope-heparan sulfate interaction. J Virol, 2006, 80: 10579-10590.
doi: 10.1128/JVI.00941-06
-
Bartosch B, Bukh J, Meunier J C, et al.In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA, 2003, 100: 14199-14204.
doi: 10.1073/pnas.2335981100
-
Bartosch B, Dubuisson J, Cosset F L. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med, 2003, 197: 633-642.
doi: 10.1084/jem.20021756
-
Bartosch B, Verney G, Dreux M, et al. An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol, 2005, 79: 8217-8229.
doi: 10.1128/JVI.79.13.8217-8229.2005
-
Bartosch B, Vitelli A, Granier C, et al. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem, 2003, 278 (43): 41624-41630.
doi: 10.1074/jbc.M305289200
-
Baumert TF, Ito S, Wong DT, et al. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol, 1998, 72: 3827-3836.
-
Blanchard E, Belouzard S, Goueslain L, et al. Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol, 2006, 80: 6964-6972.
doi: 10.1128/JVI.00024-06
-
Bowen D G, Walker C M. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature, 2005, 436: 946-952.
doi: 10.1038/nature04079
-
Boyd M R, Gustafson K R, McMahon J B, et al. Discovery of cyanovirin-N, a novel human immuno-deficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential appli-cations to microbicide development. Antimicrob Agents Chemother, 1997, 41: 1521-1530.
-
Chisari F V. Unscrambling hepatitis C virus-host interactions. Nature, 2005, 436: 930-932.
doi: 10.1038/nature04076
-
Dreux M, Pietschmann T, Granier C, et al. High density lipoprotein inhibits hepatitis C virus-neutralizing antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem, 2006, 281: 18285-18295.
doi: 10.1074/jbc.M602706200
-
Evans M J, von Hahn T, Tscherne D M, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature, 2007, 446: 801-805.
doi: 10.1038/nature05654
-
Hangartner L, Zinkernagel R M, Hengartner H. Antiviral antibody responses: the two extremes of a wide spectrum. Nat Rev Immunol, 2006, 6: 231-243.
doi: 10.1038/nri1783
-
Helle F, Goffard A, Morel V, et al. The neutralizing activity of anti-hepatitis C virus antibodies is modulated by specific glycans on the E2 envelope protein. J Virol, 2007, 81: 8101-8111.
doi: 10.1128/JVI.00127-07
-
Helle F, Wychowski C, Vu-Dac N, et al. Cyanovirin-N inhibits hepatitis C virus entry by binding to envelope protein glycans. J Biol Chem, 2006, 281: 25177-25183.
doi: 10.1074/jbc.M602431200
-
Hemler M E. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol, 2005, 6: 801-811.
doi: 10.1038/nrm1736
-
Hsu M, Zhang J, Flint M, et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci USA, 2003, 100: 7271-7276.
doi: 10.1073/pnas.0832180100
-
Kapadia S B, Barth H, Baumert T, et al. Initiation of Hepatitis C Virus Infection Is Dependent on Cholesterol and Cooperativity between CD81 and Scavenger Receptor B type Ⅰ. J Virol, 2007, 81: 374-383.
doi: 10.1128/JVI.01134-06
-
Koutsoudakis G, Herrmann E, Kallis S, et al. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells. J Virol, 2007, 81: 588-598.
doi: 10.1128/JVI.01534-06
-
Koutsoudakis G, Kaul A, Steinmann E, et al. Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses. J Virol, 2006, 80: 5308-5320.
doi: 10.1128/JVI.02460-05
-
Krieger M. Scavenger receptor class B type Ⅰ is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest, 2001, 108: 793-797.
doi: 10.1172/JCI14011
-
Kwong P D, Doyle M L, Casper D J, et al.HIV-1 evades antibody-mediated neutralization through confor-mational masking of receptor-binding sites. Nature, 2002, 420: 678-682.
doi: 10.1038/nature01188
-
Lavillette D, Morice Y, Germanidis G, et al. Human serum facilitates hepatitis C virus infection, and neutralizing responses inversely correlate with viral replication kinetics at the acute phase of hepatitis C virus infection.J Virol, 2005, 79: 6023-34.
doi: 10.1128/JVI.79.10.6023-6034.2005
-
Lee E, Pavy M, Young N, et al. Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses. Antiviral Res, 2006, 69: 31-38.
doi: 10.1016/j.antiviral.2005.08.006
-
Lindenbach B D, Evans M J, Syder A J, et al. Complete replication of hepatitis C virus in cell culture. Science, 2005, 309: 623-626.
doi: 10.1126/science.1114016
-
Lindenbach B D. Rice C M. 2001. Flaviviridae: the viruses and their replication. In: Fields Virology (Knipe D M, Howley, P M, Griffin D E, et al. ed. ), 4th ed, Baltimore, Lippincott Williams & Wilkins, p991-1041.
-
Logvinoff C, Major M E, Oldach D, et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci USA, 2004, 101: 10149-10154.
doi: 10.1073/pnas.0403519101
-
Marsh M, Helenius A. Virus entry: open sesame. Cell, 2006, 124: 729-740.
doi: 10.1016/j.cell.2006.02.007
-
Molina S, Castet V, Fournier-Wirth C, et al. The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus. J Hepatol, 2007, 46: 411-419.
doi: 10.1016/j.jhep.2006.09.024
-
O'Keefe B R, Smee D F, Turpin J A, et al. Potent anti-influenza activity of cyanovirin-N and interactions with viral hemagglutinin. Antimicrob Agents Chemother, 2003, 47: 2518-2525.
doi: 10.1128/AAC.47.8.2518-2525.2003
-
Penin F, Dubuisson J, Rey F A, et al.Structural biology of hepatitis C virus. Hepatology, 2004, 39: 5-19.
doi: 10.1002/(ISSN)1527-3350
-
Pestka J M, Zeisel M B, Blaser E, et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C. Proc Natl Acad Sci USA, 2007, 104: 6025-6030.
doi: 10.1073/pnas.0607026104
-
Pileri P, Uematsu Y, Campagnoli S, et al.Binding of hepatitis C virus to CD81. Science, 1998, 282: 938-941.
doi: 10.1126/science.282.5390.938
-
Poveda E, Briz V, Soriano V. Enfuvirtide, the first fusion inhibitor to treat HIV infection. AIDS Rev, 2005, 7: 139-147.
-
Scarselli E, Ansuini H, Cerino R, et al. The human scavenger receptor class B type Ⅰ is a novel candidate receptor for the hepatitis C virus. EMBO J, 2002, 21: 5017-5025.
doi: 10.1093/emboj/cdf529
-
Shenoy S R, O'Keefe B R, Bolmstedt A J, et al.Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.J Pharmacol Exp Ther, 2001, 297: 704-710.
-
Srivastava I K, Ulmer J B, Barnett S W. Role of neutralizing antibodies in protective immunity against HIV. Hum Vaccin, 2005, 1: 45-60.
doi: 10.4161/hv.1.2.1764
-
Steinmann D, Barth H, Gissler B, et al. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. J Virol, 2004, 78: 9030-9040.
doi: 10.1128/JVI.78.17.9030-9040.2004
-
Takaki A, Wiese M, Maertens G, et al. Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C. Nat Med, 2000, 6: 578-582.
doi: 10.1038/75063
-
Thimme R, Oldach D, Chang K M, et al. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med, 2001, 194: 1395-1406.
doi: 10.1084/jem.194.10.1395
-
Tscherne D M, Jones C T, Evans M J, et al. Time-and temperature-dependent activation of hepatitis C virus for low-pHtriggered entry. J Virol, 2006, 80: 1734-1741.
doi: 10.1128/JVI.80.4.1734-1741.2006
-
Voisset C, Callens N, Blanchard E, et al. High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type Ⅰ. J Biol Chem, 2005, 280: 7793-7799.
doi: 10.1074/jbc.M411600200
-
von Hahn T, Lindenbach BD, Boullier A, et al. Oxidized low-density lipoprotein inhibits hepatitis C virus cell entry in human hepatoma cells. Hepatology, 2006, 43: 932-942.
doi: 10.1002/(ISSN)1527-3350
-
von Hahn T, Yoon J C, Alter H, et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. Gastroenterology, 2007, 132: 667-678.
doi: 10.1053/j.gastro.2006.12.008
-
Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med, 2005, 11: 791-796.
doi: 10.1038/nm1268
-
Wellnitz S, Klumpp B, Barth H, et al. Binding of hepatitis C virus-like particles derived from infectious clone H77C to defined human cell lines. J Virol, 2002, 76: 1181-1193.
doi: 10.1128/JVI.76.3.1181-1193.2002
-
Wunschmann S, Medh J D, Klinzmann D, et al.Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor. J Virol, 2000, 74: 10055-10062.
doi: 10.1128/JVI.74.21.10055-10062.2000
-
Yamada E, Montoya M, Schuettler C G, et al.Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets. J Gen Virol, 2005, 86: 2507-2512.
doi: 10.1099/vir.0.81169-0
-
Zeisel M B, Barth H, Schuster C, et al. 2008. Hepatitis C Virus Entry: Molecular Mechanisms and Targets for Antiviral Therapy. Front Biosci, in press.
-
Zeisel M B, Fafi-Kremer S, Fofana I, et al. Host Neutralizing Responses in Hepatitis C Virus Infection. World J Gastroenterol, 2007, 13: 4824-4830.
doi: 10.3748/wjg.v13.i36.4824
-
Zeisel M B, Koutsoudakis G, Schnober E K, et al. 2007 Scavenger receptor BI is a key host factor for Hepatitis C virus infection required for an entry step closely linked to CD81.Hepatology, 46(6): 1722-1731.
doi: 10.1002/hep.v46:6
-
Zhang J, Randall G, Higginbottom A, et al. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol, 2004, 78: 1448-1455.
doi: 10.1128/JVI.78.3.1448-1455.2004
-
Zhong J, Gastaminza P, Cheng G, et al. Robust hepatitis C virus infection in vitro. Proc Natl Acad Sci USA, 2005, 102: 9294-9299.
doi: 10.1073/pnas.0503596102